Your browser doesn't support javascript.
loading
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity.
Kim, Sang-In; Park, Anthony K; Chaurasiya, Shyambabu; Kang, Seonah; Lu, Jianming; Yang, Annie; Sivanandam, Venkatesh; Zhang, Zhifang; Woo, Yanghee; Priceman, Saul J; Fong, Yuman; Warner, Susanne G.
Affiliation
  • Kim SI; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Park AK; Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Chaurasiya S; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Kang S; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Lu J; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Yang A; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Sivanandam V; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Zhang Z; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Woo Y; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Priceman SJ; Department of Surgery, Division of Surgical Oncology, City of Hope National Medical Center, Duarte, California.
  • Fong Y; Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
  • Warner SG; Department of Immuno-Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
Mol Cancer Ther ; 20(1): 173-182, 2021 01.
Article in En | MEDLINE | ID: mdl-33262221
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Orthopoxvirus / Colonic Neoplasms / Cross-Priming / Immune Checkpoint Inhibitors / Immunity / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Orthopoxvirus / Colonic Neoplasms / Cross-Priming / Immune Checkpoint Inhibitors / Immunity / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article